For many patients with chronic rhinosinusitis, functional endoscopic sinus surgery (FESS) has provided much needed relief from a condition that, by its daily aggravation, can significantly reduce quality of life.

For many patients with chronic rhinosinusitis, functional endoscopic sinus surgery (FESS) has provided much needed relief from a condition that, by its daily aggravation, can significantly reduce quality of life.
In a review of the literature published in The Cochrane Library, two Israeli authors conclude that the use of topical corticosteroid nasal sprays-either alone or in combination with antibiotic therapy-shows an advantage over placebo in the treatment of the symptoms of acute rhinosinusitis.
Affecting more than 30 million Americans, chronic rhinosinusitis (CRS) has been a frustrating disease with no long-lasting results from traditional steroidal and antibiotic treatment, or from surgery. With both clinicians and patients desperate for a solution, it is not surprising that hope-and controversy-has arisen over a potential new therapy.
An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.
Endoscopic sinus surgery is an approach commonly used by otolaryngologists–head and neck surgeons, but for what indications is it the best technique to use—and how has its use evolved over the years?
A consensus panel of physicians who treat patients reporting sinus and facial pain strongly recommend the use of all diagnostic tools available to determine the root cause of the headache-whether it is neurological or physiological, migraine or sinus.